|
|
|
|
|
About Us
|
|
Taking Stock of the Marketing Restrictions and Prohibitions of Academic Medical Centers
FDLI Update
by D. Jeffrey Campbell and Christine N. Bradshaw
Marketing in today’s regulatory environment is challenging for sales representatives, marketing teams, compliance departments and legal counsel in the life sciences industry. As more states enact laws restricting marketing activities and requiring marketing disclosures, the difficulties, both at home and in the field, grow exponentially. In March, Congress passed legislation that will require life sciences companies to track expenditures on healthcare practitioners nationwide beginning in 2012. That legislation,however,allows states to mandate additional disclosures, as well as to limit or prohibit certain marketing activities. Read entire article – click here
|
|
| |
|